News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,283 Results
Type
Article (87252)
Company Profile (732)
Press Release (770273)
Multimedia
Podcasts (164)
Webinars (26)
Section
Business (232983)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91209)
Employer Resources (201)
FDA (18248)
Job Trends (17387)
News (397215)
Policy (39901)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56979)
ALS (137)
Alzheimer's disease (1648)
Antibody-drug conjugate (ADC) (206)
Approvals (18243)
Artificial intelligence (456)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (147)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (437)
Cancer (3551)
Cardiovascular disease (311)
Career advice (3551)
Career pathing (36)
CAR-T (230)
CDC (49)
Cell therapy (630)
Cervical cancer (29)
Clinical research (74964)
Collaboration (1286)
Company closure (4)
Compensation (862)
Complete response letters (51)
COVID-19 (2941)
CRISPR (78)
C-suite (512)
Cystic fibrosis (130)
Data (3825)
Decentralized trials (2)
Denatured (58)
Depression (100)
Diabetes (426)
Diagnostics (7048)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (216)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98644)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132445)
Executive appointments (957)
FDA (20494)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1140)
Gene editing (165)
Generative AI (45)
Gene therapy (499)
GLP-1 (1000)
Government (5350)
Grass and pollen (7)
Guidances (334)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (223)
Immuno-oncology (18)
Indications (46)
Infectious disease (3160)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (166)
Interviews (815)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (626)
Leadership (31)
Legal (10144)
Liver cancer (90)
Longevity (12)
Lung cancer (512)
Lymphoma (251)
Machine learning (23)
Management (65)
Manufacturing (574)
MASH (119)
Medical device (14830)
Medtech (14848)
Mergers & acquisitions (22677)
Metabolic disorders (1083)
Multiple sclerosis (118)
NASH (23)
Neurodegenerative disease (183)
Neuropsychiatric disorders (50)
Neuroscience (2550)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (541)
Opinion (304)
Ovarian cancer (114)
Pain (154)
Pancreatic cancer (146)
Parkinson's disease (215)
Partnered (27)
Patents (385)
Patient recruitment (272)
Peanut (57)
People (66076)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23111)
Phase II (32554)
Phase III (24501)
Pipeline (2470)
Policy (281)
Postmarket research (3554)
Preclinical (10438)
Press Release (72)
Prostate cancer (174)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (601)
Real estate (7412)
Recruiting (76)
Regulatory (27705)
Reports (64)
Research institute (2676)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (120)
Series A (189)
Series B (141)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (83)
The Weekly (104)
Vaccines (1011)
Venture capital (63)
Weight loss (376)
Women's health (56)
Worklife (21)
Date
Today (135)
Last 7 days (525)
Last 30 days (2499)
Last 365 days (33924)
2025 (23822)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (297)
Arkansas (14)
Asia (50809)
Australia (8924)
California (8940)
Canada (2710)
China (844)
Colorado (378)
Connecticut (397)
Delaware (241)
Europe (116686)
Florida (1316)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (787)
India (46)
Indiana (432)
Iowa (19)
Japan (270)
Kansas (122)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1218)
Massachusetts (6734)
Michigan (295)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2464)
New Mexico (31)
New York (2431)
North Carolina (1364)
North Dakota (10)
Northern California (3975)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1860)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3404)
Tennessee (142)
Texas (1398)
United States (33149)
Utah (267)
Virginia (239)
Washington D.C. (82)
Washington State (767)
West Virginia (4)
Wisconsin (91)
There are 858,283 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy
September 18, 2025
·
6 min read
Press Releases
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
September 18, 2025
·
5 min read
Press Releases
Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer
September 18, 2025
·
2 min read
Press Releases
Patients With Aggressive Brain and Advanced Liver Cancers Treated with Geneos’ Personalized Immunotherapy for Cancer as Monotherapy Reach Five Years of Durable Recurrence-Free Survival
September 18, 2025
·
3 min read
Press Releases
Arch Strengthens its Position as a Leading Kidney Therapeutics Company with the Acquisition of a Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease (CKD)
September 18, 2025
·
9 min read
Press Releases
Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
September 18, 2025
·
5 min read
Press Releases
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
September 18, 2025
·
6 min read
Press Releases
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses
September 18, 2025
·
8 min read
Press Releases
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
September 18, 2025
·
16 min read
Press Releases
Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis
September 18, 2025
·
7 min read
1 of 85,829
Next
